GDF2 and metabolic dysfunction-associated steatotic liver disease: Our data show that BMP-9 serum levels are directly correlated with the stage of the disease in NASH/NAFLD patients, and conversely, its concentrations are inversely correlated with the severity of HCV fibrosis.